Literature DB >> 11122811

Immunotherapy for colorectal cancer.

R L Schilsky1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 11122811     DOI: 10.1007/s11912-999-0025-3

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


× No keyword cloud information.
  2 in total

1.  Monoclonal antibody therapy for resected Dukes' C colorectal cancer: seven-year outcome of a multicenter randomized trial.

Authors:  G Riethmüller; E Holz; G Schlimok; W Schmiegel; R Raab; K Höffken; R Gruber; I Funke; H Pichlmaier; H Hirche; P Buggisch; J Witte; R Pichlmayr
Journal:  J Clin Oncol       Date:  1998-05       Impact factor: 44.544

2.  Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial.

Authors:  J B Vermorken; A M Claessen; H van Tinteren; H E Gall; R Ezinga; S Meijer; R J Scheper; C J Meijer; E Bloemena; J H Ransom; M G Hanna; H M Pinedo
Journal:  Lancet       Date:  1999-01-30       Impact factor: 79.321

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.